Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Meritage Homes
MTH
$4.86B
| $9.32M | 0.01% |
152,236
-21,316
| -12% | -$1.47M |
|
1027
PUT
HCA Healthcare
HCA
$89.5B
| $9.3M | 0.01% |
37,800
-43,200
| -53% | -$11.8M |
|
1028
ARK Innovation ETF
ARKK
$6.31B
| $9.29M | 0.01% |
234,272
-88,433
| -27% | -$3.9M |
|
1029
ArcBest
ARCB
$3.08B
| $9.29M | 0.01% |
91,379
-37
| -0% | -$3.88K |
|
1030
CALL
Pfizer
PFE
$153B
| $9.29M | 0.01% |
280,000
-331,400
| -54% | -$11.7M |
|
1031
SouthState Bank Corp
SSB
$10.5B
| $9.26M | 0.01% |
137,414
-234,317
| -63% | -$16.9M |
|
1032
Reinsurance Group of America
RGA
$16.1B
| $9.22M | 0.01% |
63,525
+6,707
| +12% | +$950K |
|
|
NEWR
1033
DELISTED
New Relic, Inc.
NEWR
| $9.22M | 0.01% |
107,659
+91,087
| +550% | +$7.34M |
|
1034
KE Holdings
BEKE
$18.8B
| $8.99M | 0.01% |
579,528
+162,027
| +39% | +$2.57M |
|
1035
iShares MSCI South Korea ETF
EWY
$24.1B
| $8.98M | 0.01% |
152,373
+6,378
| +4% | +$405K |
|
1036
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.7B
| $8.98M | 0.01% |
158,948
-41,226
| -21% | -$2.43M |
|
|
SKX
1037
DELISTED
Skechers
SKX
| $8.94M | 0.01% |
182,589
+77,689
| +74% | +$3.97M |
|
1038
Valley National Bancorp
VLY
$8.04B
| $8.91M | 0.01% |
1,041,279
-205,897
| -17% | -$1.87M |
|
|
DEN
1039
DELISTED
Denbury Inc.
DEN
| $8.89M | 0.01% |
90,677
+41,973
| +86% | +$3.8M |
|
1040
Commerce Bancshares
CBSH
$8.5B
| $8.89M | 0.01% |
214,376
+7,176
| +3% | +$310K |
|
1041
Coherus Oncology
CHRS
$196M
| $8.88M | 0.01% |
2,375,557
+2,301,444
| +3,105% | +$10.6M |
|
1042
AGNC Investment
AGNC
$12.9B
| $8.84M | 0.01% |
936,716
-540,305
| -37% | -$5.35M |
|
1043
Old National Bancorp
ONB
$10.2B
| $8.78M | 0.01% |
604,182
-93,880
| -13% | -$1.45M |
|
1044
Exelixis
EXEL
$13.4B
| $8.78M | 0.01% |
401,847
-14,938
| -4% | -$312K |
|
1045
Phinia Inc
PHIN
$2.74B
| $8.77M | 0.01% |
+327,452
| New | +$9.07M |
|
1046
Associated Banc-Corp
ASB
$5.91B
| $8.74M | 0.01% |
510,974
-394,967
| -44% | -$6.95M |
|
|
TWNK
1047
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $8.72M | 0.01% |
261,859
+147,184
| +128% | +$3.94M |
|
1048
Unum
UNM
$14.3B
| $8.71M | 0.01% |
177,057
-144,946
| -45% | -$7.09M |
|
1049
iShares Silver Trust
SLV
$30.7B
| $8.7M | 0.01% |
427,636
+11,393
| +3% | +$246K |
|
1050
Vaxcyte
PCVX
$8.64B
| $8.69M | 0.01% |
170,412
+68,904
| +68% | +$3.4M |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.